Avricore Health (AVCRF) Change in Account Payables (2022 - 2023)

Avricore Health (AVCRF) posted quarterly Change in Account Payables of -$86146.3 for Q4 2023, down 384.7% year-over-year from $30258.2 in Q4 2022, and down 139.82% quarter-over-quarter from $216364.6 in Q3 2023.

Avricore Health (AVCRF) Change in Account Payables (2022 - 2023) Analysis & Trends

Avricore Health (AVCRF) has reported Change in Account Payables for 2 consecutive years, with -$86146.3 the latest figure, recorded in Q4 2023.

  • In Q4 2023, Change in Account Payables fell 384.7% year-over-year to -$86146.3; the TTM figure through Dec 2023 stood at $304113.5 (up 58.69% YoY), while the FY2024 annual figure was -$115696.0, down 188.53% from the prior year.
  • Change in Account Payables declined to -$86146.3 in Q4 2023 per AVCRF's latest filing, from $216364.6 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $216364.6 in Q3 2023 and bottomed at -$86146.3 in Q4 2023.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Thermo Fisher Scientific 213.40 Bn 209.33 Bn 8.34 Bn -
2 Danaher 139.94 Bn 135.59 Bn 3.61 Bn -38.00 Mn
3 Idexx Laboratories 46.03 Bn 45.83 Bn 779.09 Mn -6.74 Mn
4 Agilent Technologies 39.69 Bn 37.88 Bn 990.00 Mn 15.00 Mn
5 Iqvia Holdings 39.32 Bn 37.24 Bn 1.44 Bn -
6 Natera 38.47 Bn 37.37 Bn 696.04 Mn 21.88 Mn
7 Illumina 29.98 Bn 28.82 Bn 770.00 Mn 10.00 Mn
8 Mettler Toledo International 28.57 Bn 28.52 Bn 650.22 Mn 674,000.00
9 Quest Diagnostics 26.21 Bn 25.58 Bn 1.03 Bn -
10 Avricore Health 3.04 Mn 3.01 Mn -6,202.70 -

Historic Data

Download Data
DateValue
Dec 31, 2023 -86,146.33
Dec 31, 2023 -86,146.33
Sep 30, 2023 216,364.59
Sep 30, 2023 216,364.59
Dec 31, 2022 -17,772.96
Dec 31, 2022 -17,772.96
Sep 30, 2022 191,668.16
Sep 30, 2022 191,668.16